Stockreport

Onconetix announces its subsidiary, Proteomedix, licenses manufacturing IP to Immunovia enabling them to independently produce key reagents for their pancreatic cancer test PancreaSureTM [...

Onconetix, Inc.  (ONCO) 
PDF the “Company”) a commercial stage biotechnology company focused on the research, development and commercialization of innovative solutions for men's health and oncology, [Read more]